Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era by Helena Martínez-Lozano, Paula Saralegui-Gonzalez, Elena Reigadas, Pablo Ramón Fueyo-Peláez, Aurea García-García, José Miranda-Bautista, Luis Alcalá, Juan Carlos Nieto, María Elena Lobato-Matilla, Ignacio Marín-Jiménez, Patricia Muñoz, Luis Menchén

Subjects: Get full text

Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptoms by Najmeh Oliyaei, Saghar Zekri, Aida Iraji, Alireza Oliyaei, Romina Tanideh, Nadiar M. Mussin, Amin Tamadon, Nader Tanideh

Subjects: “…Seaweed, Fucoidan, Fucoxanthin, Fish oil, Inflammatory bowel disease, Ulcerative colitis.…”
Get full text

The risk of small bowel adenocarcinoma in patients with Crohn’s disease by Gustaw Lech, Wojciech Korcz, Emilia Kowalczyk, Andrzej Chaber, Maciej Słodkowski

Subjects: Get full text

Data mining and analysis of adverse events of Vedolizumab based on the FAERS database by Qinyun Xu, Jing Zhang, Weihong Tang, Minhong Zhou, Xiaoling Zhang, Pu Yuan

Subjects: Get full text

Phenotypes of primary sclerosing cholangitis in children by M.B. Dyba, V.S. Berezenko

Subjects: Get full text

Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study by Clare Harris, Richard James Harris, David Young, Martin McDonnell, Bridget Clancy, Justin Harvey, Carlos Araujo, Ines Iria, Joao Goncalves, Susan Latter, J. R. Fraser Cummings

Get full text

SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients – does treatment for IBD negatively affect SARS-CoV-2 antibodies?... by Katarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti, Katarzyna Maciejewska, Adam Tworek, Beata Stępień-Wrochna, Martyna Głuszek-Osuch, Michał Łodyga, Grażyna Rydzewska

Subjects: Get full text

The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis by Magdalena Kaniewska, Andrzej Moniuszko, Grażyna Rydzewska

Subjects: “…inflammatory bowel disease…”
Get full text

Inhibition of inflammatory cell infiltration by antagonistic peptides that specifically bind to CCR5 via regulation of the NF-kB signaling pathway in rats with colitis by Yang-Da Song, Yi-Hang Song, Si-Xue Liu, Hua-Rong Huang, Ying-Qiang Zhong

Subjects: “…inflammatory bowel disease…”
Get full text

Size exclusion chromatography as green support for forced degradation study of adalimumab by Kovačić Jelena, Klarić Daniela Amidžić, Turk Nikša, Mornar Ana

Subjects: “…inflammatory bowel disease…”
Get full text

Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet’s Disease from Immunological and Clinical Perspectives by Makoto Naganuma, Mitsuhiro Takeno, Aykut Ferhat Çelik, Robert Moots, Philippe Pinton, Tadakazu Hisamatsu

Subjects: Get full text

Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem CellsSummary by Kentaro Tominaga, Daniel O. Kechele, J. Guillermo Sanchez, Simon Vales, Ingrid Jurickova, Lizza Roman, Akihiro Asai, Jacob R. Enriquez, Heather A. McCauley, Keishi Kishimoto, Kentaro Iwasawa, Akaljot Singh, Yuko Horio, Jorge O. Múnera, Takanori Takebe, Aaron M. Zorn, Michael A. Helmrath, Lee A. Denson, James M. Wells

Subjects: Get full text

Chronic active Epstein‒Barr virus colitis, a rare cause of recurrent diarrhea in an immunocompetent female: a case report by Mei Liang, Junyan Qu

Subjects: Get full text

Association between allergic diseases and mucosal healing in ulcerative colitis by Yasunori Yamamoto, Shinya Furukawa, Osamu Yoshida, Teruki Miyake, Kana Shiraishi, Yu Hashimoto, Kazuhiro Tange, Shogo Kitahata, Tomoyuki Ninomiya, Sen Yagi, Hanayama Masakazu, Seiyuu Suzuki, Naozumi Shibata, Hidehiro Murakami, Katsuhisa Ohashi, Hideomi Tomida, Eiji Takeshita, Yoshio Ikeda, Yoichi Hiasa

Subjects: Get full text

Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics by Riccardo Rampado, Gonna Somu Naidu, Olga Karpov, Meir Goldsmith, Preeti Sharma, Assaf Ezra, Lior Stotsky, Dor Breier, Dan Peer

Subjects: Get full text

Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions by Elena Lucarini, Javier Aguilera-Lizarraga, Miguel Ángel Tejada, Miguel Ángel Tejada, Miguel Ángel Tejada

Subjects: Get full text

Genome analysis of Bifidobacterium adolescentis and investigation of its effects on inflammation and intestinal barrier function by Bo Li, Bo Li, Haoyu Wang, Haoyu Wang, Haoyu Wang, Mengmeng Wang, Mengmeng Wang, Hewei Liang, Hewei Liang, Hewei Liang, Tongyuan Hu, Tongyuan Hu, Tongyuan Hu, Jinlong Yang, Jinlong Yang, Jinlong Yang, Shangyong Li, Xinbi You, Xinbi You, Xinbi You, Binbin Xia, Binbin Xia, Binbin Xia, Yue Yuan, Yue Yuan, Yuanqiang Zou, Yuanqiang Zou, Yinglei Miao, Yinglei Miao, Yang Sun, Yang Sun, Yang Sun

Subjects: Get full text

Examination of non-conventional dysplasias adjacent to colorectal adenocarcinoma in patients with IBD by Szintia Almási, Zsófia Balajthy, Bence Baráth, Zsófia Krisztina Török, Panna Szaszák, Tamás Lantos, Bence Kővári, Anita Sejben

Subjects: Get full text

A foundation systematic review of natural language processing applied to gastroenterology & hepatology by Matthew Stammers, Balasubramanian Ramgopal, Abigail Owusu Nimako, Anand Vyas, Reza Nouraei, Cheryl Metcalf, James Batchelor, Jonathan Shepherd, Markus Gwiggner

Subjects: Get full text

Co-existing ulcerative colitis and takayasu arteritis: A case-based review by Karan Rajgopal Kalani, Anuj Achyut Ban, Sumeet Singla

Subjects: Get full text